Pathology Department, Parc Tauli University Hospital, Sabadell, Sabadell, Barcelona, Spain.
Coloproctology Unit, General and Digestive Surgery Department, Parc Tauli University Hospital, Sabadell, Parc Tauli s/n, 08208, Sabadell, Barcelona, Spain.
J Gastrointest Surg. 2021 Oct;25(10):2660-2667. doi: 10.1007/s11605-021-04948-9. Epub 2021 Feb 24.
Surgical treatment of early rectal cancer T1 is either local excision or total mesorectal excision. The choice of surgery is based on the risk of metastatic lymph node involvement. The most important factor to consider is the degree of submucosal invasion. We present a different way to measure tumoral invasion derived from the measurement of the healthy residual submucosa with its prognosis and therapeutic implications METHODS: Observational study of tumor submucosal invasion in patients undergoing transanal endoscopic microsurgery was conducted. Parameters evaluated are submucosal invasion, measuring the healthy residual submucosa at the point of maximum invasion; macroscopic morphology of the tumor; presence of muscularis mucosa, muscularis propria, and measurement of submucosa in the tumor area and the healthy area. The classification proposed is compared with the ones previously published.
Eighty consecutive patients diagnosed with T1 rectal cancer underwent transanal endoscopic microsurgery. Seventeen tumors (21.3%) were polypoid. En bloc resection was achieved in 77 (96.3%). The muscularis mucosa was present in 28 (35%), and the muscularis propria in 77 (96.3%) (p < 0.001). The healthy residual submucosa in the tumor area measured 2,343 ± 1,869 μm. Agreement was moderate with the Kikuchi classification (kappa 0.58) and very good with the Kudo classification (kappa 0.87).
We describe a method for measuring submucosal invasion in T1 rectal cancer which does not depend on the morphology of the lesion or on the presence of the muscularis mucosa. It can be applied to all T1 classifications of the digestive tract in which the muscularis propria is present.
早期 T1 期直肠肿瘤的外科治疗方法为局部切除或直肠系膜全切除。手术选择取决于淋巴结转移的风险。最需要考虑的因素是黏膜下侵犯的程度。我们提出了一种不同的方法来测量肿瘤侵犯程度,该方法源于对最大侵犯点的健康黏膜下剩余部分的测量,并探讨其预后和治疗意义。
对接受经肛门内镜微创手术的患者进行肿瘤黏膜下侵犯的观察性研究。评估的参数包括黏膜下侵犯,测量最大侵犯点的健康黏膜下剩余部分;肿瘤的大体形态;黏膜肌层和固有肌层的存在,以及肿瘤区域和健康区域黏膜下的测量。与之前发表的分类方法进行比较。
80 例连续诊断为 T1 期直肠腺癌的患者接受了经肛门内镜微创手术。17 个肿瘤(21.3%)为息肉样。77 例(96.3%)实现了整块切除。28 例(35%)存在黏膜肌层,77 例(96.3%)存在固有肌层(p < 0.001)。肿瘤区域的健康黏膜下剩余部分测量值为 2343±1869μm。与 Kikuchi 分类法的一致性为中度(kappa 0.58),与 Kudo 分类法的一致性为极好(kappa 0.87)。
我们描述了一种测量 T1 期直肠腺癌黏膜下侵犯的方法,该方法不依赖于病变的形态或黏膜肌层的存在。它可以应用于存在固有肌层的所有消化道 T1 分类中。